Ajanta Pharma Limited — Updates, 02-07-2026: General Updates
02-07-2026 | 01:56 pm
02-07-2026 | 01:56 pm
Ajanta Pharma's Paithan facility received a USFDA Establishment Inspection Report (EIR), with the inspection classified as Voluntary Action Indicated (VAI). This outcome supports continued operations for the US market.
No comments yet. Be the first to comment!
